Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Name: Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'
Creator: Garrett Mullins
Published: 2024-04-22T13:19:37.414Z
Keywords: Immunogenicity, Clinical Trial Results

Mullins, Garrett; Hodsdon, Michael E.; Li, Ying Grace; Anglin, Greg; Urva, Shweta; Schneck, Karen; Bardos, Jennifer N.; Fonseca Martins, Ricardo; Brown, Katelyn; Calderon, Boris

doi:10.17632/dxthnf38zx.2

Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Published: 22 April 2024| Version 2 | DOI: 10.17632/dxthnf38zx.2

Contributors:

Garrett Mullins, Michael E. Hodsdon, Ying Grace Li, Greg Anglin, Shweta Urva, Karen Schneck, Jennifer N. Bardos, Ricardo Fonseca Martins, Katelyn Brown, Boris Calderon

Description

Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Files

Funders

Eli Lilly (United States)
United States

Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Description

Files

Categories

Funders

Licence